666 results on '"O’Hehir, Robyn E."'
Search Results
2. Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants
3. COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants
4. Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on basophils (CytoBas)
5. Subcutaneous immunotherapy for bee venom allergy induces epitope spreading and immunophenotypic changes in allergen-specific memory B cells
6. Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants
7. Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling
8. Allergen-Specific Immunotherapy
9. Preface
10. Contributors
11. A recent patent in allergy & immunology:Biomarkers on allergen-specific memory B cells to predict allergen immunotherapy outcome
12. Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency
13. Collagen—An Important Fish Allergen for Improved Diagnosis
14. Paradoxical Vocal Fold Motion in Difficult Asthma Is Associated with Dysfunctional Breathing and Preserved Lung Function
15. Systematic Assessment for Difficult and Severe Asthma Improves Outcomes and Halves Oral Corticosteroid Burden Independent of Monoclonal Biologic Use
16. IgE in allergy: It takes two
17. Defining specific allergens for improved component-resolved diagnosis of shrimp allergy in adults
18. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study
19. Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy—An NIAID/AHRQ Workshop
20. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
21. Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after with mRNA but not adenovirus priming
22. A recent patent in allergy & immunology: Biomarkers on allergen‐specific memory B cells to predict allergen immunotherapy outcome.
23. Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on Basophils (CytoBas)
24. The changing global prevalence of asthma and atopic dermatitis
25. Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy.
26. Trait profiles in difficult‐to‐treat asthma: Clinical impact and response to systematic assessment
27. Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet
28. COVID-19 adenoviral vector vaccination elicits a robust memory B cell response with the capacity to recognize Omicron BA.2 and BA.5 variants
29. Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis
30. The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2
31. Phenotypic Distinctions Between Omega-5-Gliadin Allergy and Peanut Allergy: Clinical Profile, Reaction Rates and Triggers, and Quality of Life
32. Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
33. RNA sequencing of single allergen‐specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect
34. Transient acquired donor peanut allergy presenting as life-threatening anaphylaxis following lung transplantation
35. New insights into human immune memory from SARS‐CoV ‐2 infection and vaccination
36. Peanut Allergy Biomolecular Characterization for Development of a Peanut T-Cell Epitope Peptide Therapy
37. Dedication
38. Preface
39. Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
40. Phenotypic Distinctions Between Omega-5-Gliadin Allergy and Peanut Allergy: Clinical Profile, Reaction Rates and Triggers, and Quality of Life
41. The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2.
42. RNA sequencing of single allergen‐specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect.
43. 6 - Allergen-Specific Immunotherapy
44. Peptide Mediated Regulation of Allergen Specific Immune Responses
45. The dominant 55 kDa allergen of the subtropical Bahia grass (Paspalum notatum) pollen is a group 13 pollen allergen, Pas n 13
46. Ara h 2 peptides containing dominant CD4+ T-cell epitopes: Candidates for a peanut allergy therapeutic
47. Peanut oral immunotherapy: current trends in clinical trials
48. Assessment of thunderstorm-induced asthma using Google Trends
49. Adrenaline And Non-Life Threatening Allergic Reactions
50. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air (R)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.